# FDA Inspection 1195105 - ATSF NW Office - January 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/atsf-nw-office/44e7912f-e334-4af6-bac8-6f34f9aa1bec
Source feed: FDA_Inspections

> FDA Inspection 1195105 for ATSF NW Office on January 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195105
- Company Name: ATSF NW Office
- Inspection Date: 2023-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1195105 - 2023-01-11](https://www.keypedia.com/records/fda_inspections/atsf-nw-office/3edc3edb-740a-4a2a-814e-73923473cb82)
- [FDA Inspection 1195105 - 2023-01-11](https://www.keypedia.com/records/fda_inspections/atsf-nw-office/865e33e0-2fe8-4193-8136-71375fdf19ac)
- [FDA Inspection 1061150 - 2018-07-09](https://www.keypedia.com/records/fda_inspections/atsf-nw-office/585db0ff-b711-4e54-8c8b-c6f34f67443c)
- [FDA Inspection 1061150 - 2018-07-09](https://www.keypedia.com/records/fda_inspections/atsf-nw-office/303d44d1-f6ac-4422-9618-2d982a4c2431)
- [FDA Inspection 985587 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/atsf-nw-office/3ff6496c-5a81-4dd9-b438-d280f92d7070)

Company: https://www.keypedia.com/companies/atsf-nw-office/b47f460a-adab-488c-92ac-537b4edac41e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d